Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JATT Acquisition Corp was a special purpose acquisition company (SPAC) focused on the healthcare and biotechnology sector. It completed a business combination with Zura Bio Limited, a clinical-stage immunology-focused biotech, in March 2023. JATT is now defunct and the resulting entity is Zura Bio Limited, which is actively developing multiple antibody therapies for immune and inflammatory diseases[1][2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JATT Acquisition Corp.